APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Patient Health Record Analysis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Patient Health Record Analysis Market Outlook and Growth Opportunities 2026

Report ID 17444184054 July 2026192 pages

Choose your research edition.

Industry ResearchPatient Health Record Analysis Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Patient Health Record Analysis Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Patient Health Record Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Patient Health Record Analysis Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Patient Health Record Analysis Market Analysis and Forecast 2026-2032177 pages · $4,950 USD

Market perspective

The global Patient Health Record Analysis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Patient Health Record Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Patient Health Record Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Patient Health Record Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Patient Health Record Analysis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Patient Health Record Analysis market include Next IT Corporation, iCarbonX, Octopus, Enlitic, Inc., Welltok, IBM Corporation, Microsoft Corporation, General Vision, Inc. and Google Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Patient Health Record Analysis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Patient Health Record Analysis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Patient Health Record Analysis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Patient Health Record Analysis market.

Patient Health Record Analysis Segment by Company

Next IT Corporation

iCarbonX

Octopus

Enlitic, Inc.

Welltok

IBM Corporation

Microsoft Corporation

General Vision, Inc.

Google Inc.

Intel Corporation

Nvidia Corporation

Sweetch Health Ltd.

Superwise.ai

Patient Health Record Analysis Segment by Type

Machine Learning

NLP

Patient Health Record Analysis Segment by Application

Hospital

Diagnostic Centers

Ambulatory Surgical Centers

Others

Patient Health Record Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Patient Health Record Analysis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Patient Health Record Analysis key companies, revenue, market share, and recent developments.

3. To split the Patient Health Record Analysis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Patient Health Record Analysis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Patient Health Record Analysis significant trends, drivers, influence factors in global and regions.

6. To analyze Patient Health Record Analysis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Patient Health Record Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Patient Health Record Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Patient Health Record Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Patient Health Record Analysis industry.

Chapter 3: Detailed analysis of Patient Health Record Analysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Patient Health Record Analysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Patient Health Record Analysis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Patient Health Record Analysis Industry Trends Table 2. Patient Health Record Analysis Industry Drivers Table 3. Patient Health Record Analysis Industry Opportunities and Challenges Table 4. Patient Health Record Analysis Industry Restraints Table 5. Global Patient Health Record Analysis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Patient Health Record Analysis Revenue Share by Company (2021-2026) Table 7. Global Patient Health Record Analysis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Patient Health Record Analysis Key Company Manufacturing Base & Headquarters Table 9. Global Patient Health Record Analysis Company, Product Type & Application Table 10. Global Patient Health Record Analysis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Patient Health Record Analysis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Machine Learning Table 15. Significant Companies of NLP Table 16. Global Patient Health Record Analysis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Patient Health Record Analysis Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Patient Health Record Analysis Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Patient Health Record Analysis Sales Value Share by Type (2021-2026) Table 20. Global Patient Health Record Analysis Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Diagnostic Centers Table 23. Significant Companies of Ambulatory Surgical Centers Table 24. Significant Companies of Others Table 25. Global Patient Health Record Analysis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Patient Health Record Analysis Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Patient Health Record Analysis Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Patient Health Record Analysis Sales Value Share by Application (2021-2026) Table 29. Global Patient Health Record Analysis Sales Value Share by Application (2027-2032) Table 30. Global Patient Health Record Analysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Patient Health Record Analysis Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Patient Health Record Analysis Sales Value Share by Region (2021-2026) Table 33. Global Patient Health Record Analysis Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Patient Health Record Analysis Sales Value Share by Region (2027-2032) Table 35. Global Patient Health Record Analysis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Patient Health Record Analysis Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Patient Health Record Analysis Sales Value Market Share by Country (2021-2026) Table 38. Global Patient Health Record Analysis Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Patient Health Record Analysis Sales Value Market Share by Country (2027-2032) Table 40. Next IT Corporation Company Information Table 41. Next IT Corporation Business Overview Table 42. Next IT Corporation Patient Health Record Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Next IT Corporation Patient Health Record Analysis Product Portfolio Table 44. Next IT Corporation Recent Development Table 45. iCarbonX Company Information Table 46. iCarbonX Business Overview Table 47. iCarbonX Patient Health Record Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. iCarbonX Patient Health Record Analysis Product Portfolio Table 49. iCarbonX Recent Development Table 50. Octopus Company Information Table 51. Octopus Business Overview Table 52. Octopus Patient Health Record Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Octopus Patient Health Record Analysis Product Portfolio Table 54. Octopus Recent Development Table 55. Enlitic, Inc. Company Information Table 56. Enlitic, Inc. Business Overview Table 57. Enlitic, Inc. Patient Health Record Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Enlitic, Inc. Patient Health Record Analysis Product Portfolio Table 59. Enlitic, Inc. Recent Development Table 60. Welltok Company Information Table 61. Welltok Business Overview Table 62. Welltok Patient Health Record Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Welltok Patient Health Record Analysis Product Portfolio Table 64. Welltok Recent Development Table 65. IBM Corporation Company Information Table 66. IBM Corporation Business Overview Table 67. IBM Corporation Patient Health Record Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. IBM Corporation Patient Health Record Analysis Product Portfolio Table 69. IBM Corporation Recent Development Table 70. Microsoft Corporation Company Information Table 71. Microsoft Corporation Business Overview Table 72. Microsoft Corporation Patient Health Record Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Microsoft Corporation Patient Health Record Analysis Product Portfolio Table 74. Microsoft Corporation Recent Development Table 75. General Vision, Inc. Company Information Table 76. General Vision, Inc. Business Overview Table 77. General Vision, Inc. Patient Health Record Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. General Vision, Inc. Patient Health Record Analysis Product Portfolio Table 79. General Vision, Inc. Recent Development Table 80. Google Inc. Company Information Table 81. Google Inc. Business Overview Table 82. Google Inc. Patient Health Record Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Google Inc. Patient Health Record Analysis Product Portfolio Table 84. Google Inc. Recent Development Table 85. Intel Corporation Company Information Table 86. Intel Corporation Business Overview Table 87. Intel Corporation Patient Health Record Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Intel Corporation Patient Health Record Analysis Product Portfolio Table 89. Intel Corporation Recent Development Table 90. Nvidia Corporation Company Information Table 91. Nvidia Corporation Business Overview Table 92. Nvidia Corporation Patient Health Record Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Nvidia Corporation Patient Health Record Analysis Product Portfolio Table 94. Nvidia Corporation Recent Development Table 95. Sweetch Health Ltd. Company Information Table 96. Sweetch Health Ltd. Business Overview Table 97. Sweetch Health Ltd. Patient Health Record Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Sweetch Health Ltd. Patient Health Record Analysis Product Portfolio Table 99. Sweetch Health Ltd. Recent Development Table 100. Superwise.ai Company Information Table 101. Superwise.ai Business Overview Table 102. Superwise.ai Patient Health Record Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Superwise.ai Patient Health Record Analysis Product Portfolio Table 104. Superwise.ai Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Patient Health Record Analysis Product Image Figure 2. Global Patient Health Record Analysis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Patient Health Record Analysis Market Size (2021-2032) & (US$ Million) Figure 4. Global Patient Health Record Analysis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Machine Learning Image Figure 8. NLP Image Figure 9. Global Patient Health Record Analysis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Patient Health Record Analysis Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Patient Health Record Analysis Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Diagnostic Centers Image Figure 14. Ambulatory Surgical Centers Image Figure 15. Others Image Figure 16. Global Patient Health Record Analysis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Patient Health Record Analysis Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Patient Health Record Analysis Sales Value Share by Application (2021-2032) Figure 19. Global Patient Health Record Analysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Patient Health Record Analysis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Patient Health Record Analysis Sales Value (2021-2032) & (US$ Million) Figure 22. North America Patient Health Record Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Patient Health Record Analysis Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Patient Health Record Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Patient Health Record Analysis Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Patient Health Record Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Patient Health Record Analysis Sales Value (2021-2032) & (US$ Million) Figure 28. South America Patient Health Record Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Patient Health Record Analysis Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Patient Health Record Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Patient Health Record Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Machine Learning
  • NLP
Applications
  • Hospital
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Others
Companies covered
  • Next IT Corporation
  • iCarbonX
  • Octopus
  • Enlitic, Inc.
  • Welltok
  • IBM Corporation
  • Microsoft Corporation
  • General Vision, Inc.
  • Google Inc.
  • Intel Corporation
  • Nvidia Corporation
  • Sweetch Health Ltd.
  • Superwise.ai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Patient Health Record Analysis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Patient Health Record Analysis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Patient Health Record Analysis Market Dynamics
  1. 2.1 Patient Health Record Analysis Industry Trends
  2. 2.2 Patient Health Record Analysis Industry Drivers
  3. 2.3 Patient Health Record Analysis Industry Opportunities and Challenges
  4. 2.4 Patient Health Record Analysis Industry Restraints
3 Patient Health Record Analysis Market by Company
  1. 3.1 Global Patient Health Record Analysis Company Revenue Ranking in 2025
  2. 3.2 Global Patient Health Record Analysis Revenue by Company (2021-2026)
  3. 3.3 Global Patient Health Record Analysis Company Ranking (2024-2026)
  4. 3.4 Global Patient Health Record Analysis Company Manufacturing Base and Headquarters
  5. 3.5 Global Patient Health Record Analysis Company Product Type and Application
  6. 3.6 Global Patient Health Record Analysis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Patient Health Record Analysis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Patient Health Record Analysis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Patient Health Record Analysis Market by Type
  1. 4.1 Patient Health Record Analysis Type Introduction
  2. 4.1.1 Machine Learning
  3. 4.1.2 NLP
  4. 4.2 Global Patient Health Record Analysis Sales Value by Type
  5. 4.2.1 Global Patient Health Record Analysis Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Patient Health Record Analysis Sales Value by Type (2021-2032)
  7. 4.2.3 Global Patient Health Record Analysis Sales Value Share by Type (2021-2032)
5 Patient Health Record Analysis Market by Application
  1. 5.1 Patient Health Record Analysis Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Diagnostic Centers
  4. 5.1.3 Ambulatory Surgical Centers
  5. 5.1.4 Others
  6. 5.2 Global Patient Health Record Analysis Sales Value by Application
  7. 5.2.1 Global Patient Health Record Analysis Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Patient Health Record Analysis Sales Value by Application (2021-2032)
  9. 5.2.3 Global Patient Health Record Analysis Sales Value Share by Application (2021-2032)
6 Patient Health Record Analysis Regional Value Analysis
  1. 6.1 Global Patient Health Record Analysis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Patient Health Record Analysis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Patient Health Record Analysis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Patient Health Record Analysis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Patient Health Record Analysis Sales Value (2021-2032)
  7. 6.3.2 North America Patient Health Record Analysis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Patient Health Record Analysis Sales Value (2021-2032)
  10. 6.4.2 Europe Patient Health Record Analysis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Patient Health Record Analysis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Patient Health Record Analysis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Patient Health Record Analysis Sales Value (2021-2032)
  16. 6.6.2 South America Patient Health Record Analysis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Patient Health Record Analysis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Patient Health Record Analysis Sales Value Share by Country, 2025 VS 2032
7 Patient Health Record Analysis Country-level Value Analysis
  1. 7.1 Global Patient Health Record Analysis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Patient Health Record Analysis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Patient Health Record Analysis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Patient Health Record Analysis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Patient Health Record Analysis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Patient Health Record Analysis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Patient Health Record Analysis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Next IT Corporation
  2. 8.1.1 Next IT Corporation Company Information
  3. 8.1.2 Next IT Corporation Business Overview
  4. 8.1.3 Next IT Corporation Patient Health Record Analysis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Next IT Corporation Patient Health Record Analysis Product Portfolio
  6. 8.1.5 Next IT Corporation Recent Developments
  7. 8.2 iCarbonX
  8. 8.2.1 iCarbonX Company Information
  9. 8.2.2 iCarbonX Business Overview
  10. 8.2.3 iCarbonX Patient Health Record Analysis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 iCarbonX Patient Health Record Analysis Product Portfolio
  12. 8.2.5 iCarbonX Recent Developments
  13. 8.3 Octopus
  14. 8.3.1 Octopus Company Information
  15. 8.3.2 Octopus Business Overview
  16. 8.3.3 Octopus Patient Health Record Analysis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Octopus Patient Health Record Analysis Product Portfolio
  18. 8.3.5 Octopus Recent Developments
  19. 8.4 Enlitic, Inc.
  20. 8.4.1 Enlitic, Inc. Company Information
  21. 8.4.2 Enlitic, Inc. Business Overview
  22. 8.4.3 Enlitic, Inc. Patient Health Record Analysis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Enlitic, Inc. Patient Health Record Analysis Product Portfolio
  24. 8.4.5 Enlitic, Inc. Recent Developments
  25. 8.5 Welltok
  26. 8.5.1 Welltok Company Information
  27. 8.5.2 Welltok Business Overview
  28. 8.5.3 Welltok Patient Health Record Analysis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Welltok Patient Health Record Analysis Product Portfolio
  30. 8.5.5 Welltok Recent Developments
  31. 8.6 IBM Corporation
  32. 8.6.1 IBM Corporation Company Information
  33. 8.6.2 IBM Corporation Business Overview
  34. 8.6.3 IBM Corporation Patient Health Record Analysis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 IBM Corporation Patient Health Record Analysis Product Portfolio
  36. 8.6.5 IBM Corporation Recent Developments
  37. 8.7 Microsoft Corporation
  38. 8.7.1 Microsoft Corporation Company Information
  39. 8.7.2 Microsoft Corporation Business Overview
  40. 8.7.3 Microsoft Corporation Patient Health Record Analysis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Microsoft Corporation Patient Health Record Analysis Product Portfolio
  42. 8.7.5 Microsoft Corporation Recent Developments
  43. 8.8 General Vision, Inc.
  44. 8.8.1 General Vision, Inc. Company Information
  45. 8.8.2 General Vision, Inc. Business Overview
  46. 8.8.3 General Vision, Inc. Patient Health Record Analysis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 General Vision, Inc. Patient Health Record Analysis Product Portfolio
  48. 8.8.5 General Vision, Inc. Recent Developments
  49. 8.9 Google Inc.
  50. 8.9.1 Google Inc. Company Information
  51. 8.9.2 Google Inc. Business Overview
  52. 8.9.3 Google Inc. Patient Health Record Analysis Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Google Inc. Patient Health Record Analysis Product Portfolio
  54. 8.9.5 Google Inc. Recent Developments
  55. 8.10 Intel Corporation
  56. 8.10.1 Intel Corporation Company Information
  57. 8.10.2 Intel Corporation Business Overview
  58. 8.10.3 Intel Corporation Patient Health Record Analysis Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Intel Corporation Patient Health Record Analysis Product Portfolio
  60. 8.10.5 Intel Corporation Recent Developments
  61. 8.11 Nvidia Corporation
  62. 8.11.1 Nvidia Corporation Company Information
  63. 8.11.2 Nvidia Corporation Business Overview
  64. 8.11.3 Nvidia Corporation Patient Health Record Analysis Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nvidia Corporation Patient Health Record Analysis Product Portfolio
  66. 8.11.5 Nvidia Corporation Recent Developments
  67. 8.12 Sweetch Health Ltd.
  68. 8.12.1 Sweetch Health Ltd. Company Information
  69. 8.12.2 Sweetch Health Ltd. Business Overview
  70. 8.12.3 Sweetch Health Ltd. Patient Health Record Analysis Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sweetch Health Ltd. Patient Health Record Analysis Product Portfolio
  72. 8.12.5 Sweetch Health Ltd. Recent Developments
  73. 8.13 Superwise.ai
  74. 8.13.1 Superwise.ai Company Information
  75. 8.13.2 Superwise.ai Business Overview
  76. 8.13.3 Superwise.ai Patient Health Record Analysis Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Superwise.ai Patient Health Record Analysis Product Portfolio
  78. 8.13.5 Superwise.ai Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst